SMi EVENT – 7th annual Orphan Drugs and Rare Diseases UK!

SMi Group is thrilled to present the 7th annual Orphan Drugs and Rare Diseases conference, taking place on 18th & 19th October 2017 in Central London, UK. This year’s theme will be focused towards discussing strategies for patient engagement, market access and gene therapies to enhance rare diseases and orphan drug research.

200 X 200 copykiuj

Aimed at an audience of senior scientists and oncology specialists involved in targeting rare diseases therapies and drug research, Orphan Drugs UK 2017 will provide a perfect platform to discuss pioneering clinical developments and the next generation of clinical trial process. The 7th annual conference will capture expert insight through dedicated focus new therapies for different rare diseases, the importance of orphan drug development and reimbursement and repurposing.

Join us this October for strategic direction from the Rare Disease community and leverage your knowledge with the key requirements and tools for successful patient recruitment and retention through informed guidance delivered by a panel of industry experts.

 

Exclusive highlights in 2017:

  • Learn about new therapies for different rare diseases, and how these can successfully be applied to other diseases with similar attributes
  • Hear what opportunities and challenges come with working on rare diseases, as well as the development of the world’s first rare disease centre for children
  • Expand your knowledge on patient collaboration and patient centric models with the stream on patient engagement, covering improvement strategies, patient-led trials, and much more
  • Gather further insight on drug approval and reimbursement with MAA, and how techniques for drug repurposing in the rare disease area can help treatment.

For more information visit the website at www.orphandrugs.co.uk/bentham or contact the team on email: kwilliams@smi-online.co.uk or call +44 (0) 207 827 6012

Journal: Current Medicinal Chemistry

EBook: Frontiers in Anti-Cancer Drug Discovery Volume 6

SMi EVENT – 6th annual Cancer Vaccines Conference 2017

SMi Group is thrilled to present the 6th annual Cancer Vaccines conference, taking place on 27th & 28th September 2017 in Central London, UK. Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.

200 x 200 copy

Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2017 will provide a perfect platform to discuss pioneering clinical developments and the next generation of cancer immunotherapy. The 6th annual show will capture expert insight by honing in on new pathways with novel vaccines and immunotherapies, drug formulations, personalised treatment, immune check-point inhibitors, plus more.

Join us this September for strategic direction on vaccine commercialisation and arm yourself with the key requirements and tools for successful vaccine development through informed guidance delivered by a top panel of speakers.

Exclusive highlights in 2017:

  • Exploring personalising cancer vaccines, characterising and applying the outside in approach in cancer vaccine development
  • Maximising the therapeutic potential of cancer vaccines in combination with immune checkpoint inhibitors
  • In depth case study examples of peptide, DNA, neoantigen and MHC based vaccine development
  • Assessing the use of preclinical data for cancer vaccines

For more information visit the website at www.cancervaccinesevent.com/bentham  or contact the team on email: kwilliams@smi-online.co.uk or call +44 (0) 207 827 6012

Journal: Current Cancer Drug Targets

EBook: Topics in Anti-Cancer Research Volume 4

SMi EVENT – Microbiology East Coast 2017

Drawing on from the huge success of SMi’s Pharmaceutical Microbiology event series, SMi is delighted to announce the launch of Pharmaceutical Microbiology East Coast. Being the eighth in its series, this event will take place in New Jersey, USA, on November 13th and 14th 2017.

200 x 200 copy.jpg

Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology East Coast 2017 will address the best practices for rapid microbial and sterility testing and tackle the challenges of contamination control.

Pharmaceutical Microbiology East Coast has been produced with a vision of promoting the field of microbiology, and has been tailored to address the current issues and opportunities the industry faces every day. Topics of interest will include:

  • The role of microbiology in pharmaceutical stability programs
  • Deciphering the host-microbe interaction
  • Benefits of real-time monitoring of airborne viable microorganisms
  • Current expectations for a complete environmental monitoring program
  • Quality control strategy on low endotoxin recovery (LER)
  • Implementation of a global electronic intervention logging system

For more information visit the website at www.microbiologyeastcoast.com/bentham or contact the team on email: kwilliams@smi-online.co.uk or call +44 (0) 207 827 6012

Journal: Anti-Infective Agents 

EBook: Anti-Infective Drug Discovery Volume 3

SMi EVENT – Superbugs and Superdrugs USA 2017

Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group are thrilled to announce the return of Superbugs and Superdrugs USA which arrives to Iselin, New Jersey on November 13th & 14th 2017.

200X200-Superbugs

Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases. Innovation and collaboration is requested at every level making Superbugs & Superdrugs USA, the perfect platform to strengthen knowledge in key principles such as funding incentives and global strategy, whilst honing in on clinical developments in areas such as immunotherapy, toxoid based vaccines and anti-body drug conjugates. As methods move away from traditional small molecule antibiotics, this is critical time for AMR experts, government bodies and industry leaders, to come together and share ideas on the latest developments in treatment and prevention. Featured speakers include: Janssen, UNT Health Science Center, John Rex from CARB-X, BARDA, Pfizer, Merck, DemovaMed, Visterrra, Microbiotix more.

For more information visit the website at http://www.superbugs-usa.com/bentham or contact the team on email: events@smi-online.co.uk or call +44 (0)20 7827 6000

Journal: Anti-Infective Agents 

EBook: Frontiers in Anti-Infective Drug Discovery

SMi EVENT – In Vitro Diagnostics 2017

The third in its series, SMi is delighted to announce the return of In Vitro Diagnostics taking place in London on the 14th & 15th June 2017.

IVD 150x150 copy

Aimed at Managers/Heads and Directors of Regulatory Affairs, In Vitro Diagnostics, Clinical Affairs and Quality Assurance, IVDs 2017  will provide regulatory updates and key industry feedback from leading IVD manufacturers within this complex and ever-changing landscape.

Through a series of presentations from handpicked industry experts and Notified Bodies, the 2017 event will prepare attendees for the challenging times ahead and how to comply with regulatory requirements to ensure direct access to market ensuring the continued growing demand for use and innovation of IVDs over the next decade and beyond. Topics of discussion include: Latest updates on the IVD regulation, the changing role of notified bodies as well as the increase in requirements for clinical evidence.

For details or to register, visit the website at www.in-vitro-diagnostics.co.uk/benthamscience or contact the team at +44(0) 207827 6000, email kobanigba@smi-online.co.uk

Journal: Applied Clinical Research, Clinical Trials and Regulatory Affairs

EBook: The Role of New Technologies in Medical Microbiological Diagnosis and Research

SMi EVENT – 4th annual Allergies Conference

SMi is proud to present its 4th annual Allergies conference which returns to London in July 2017 to reflect on the ongoing issues and latest developments in this field.

Allergies

This year’s event will bring together industry leaders to discuss the latest challenges and changes in the fields of allergen immunotherapy. We will explore novel approaches to treatment, biomarkers and targeted treatments. The challenges to device development and drug delivery will be identified to deepen delegates understanding of the problems relating to these diseases, and discuss the topic of standardisation.

As the prevalence of allergic diseases has increased so has diagnostic technology. Additionally, cutting edge developments in targeted drugs and preventative measures are currently revolutionising the ways in which pharmaceutical and biotech companies are addressing allergies.

Presentations and selected case studies from industry experts on paediatric allergies and immunotherapy, novel approaches to treatment, key decision makers in these fields and unique networking opportunities will make this an event a not to miss opportunity.

Visit the website for further details at www.allergies-event.com/bentham or contact at kwilliams@smi-online.co.uk

Journal: Recent Patents on Inflammation & Allergy Drug Discovery

EBook: Immune Response to Parasitic Infections Volume 2 – Immunity to Helminths and Novel Therapeutic Approaches

SMi EVENT – 4th annual Immunogenicity

SMi is thrilled to present the return of its 4th annual Immunogenicity conference and exhibition, taking place in London on the 12th – 13th June 2017.

immuno

The immunogenicity market has seen considerable progression over recent years, with innovative developments apparent in predicting and controlling immunogenicity. However the industry is still subject to complex hurdles and challenges.

This year’s conference will provide attendees with a thorough understanding of the continued need for harmonisation across risk assessments and data reporting, as well as guidance for clinical trial design. Speakers will offer deep exploration of the regulations surrounding immunogenicity testing, from the UK, Europe, and USA, giving exclusive opportunity for discussion and debate with key regulatory experts. With focus on delivering true value for all delegates in attendance, Immunogenicity 2017 will identify and solve key challenges for industry experts. Insight into aggregations, next generation biologics, novel assays, humanisation of bio-therapeutics, and improvements to accurate risk assessment will be complemented by high level case studies.

At SMi’s 4th annual Immunogenicity conference, industry, regulatory and academic experts will gather to spark debate and progress on the causes of immunogenicity, predicting and preventing its effects, and its associated issues. Immunogenicity 2017 will offer unparalleled networking opportunities, deep insight into industry issues, and spotlight sessions on innovations and emerging technologies for immunogenicity.

Visit the website for further details at www.immuno.co.uk/bentham or contact at kwilliams@smi-online.co.uk

Journal: Current Immunology Reviews 

EBook: The Inflammatory Milieu of Tumors: Cytokines and Chemokines that Affect Tumor Growth and Metastasis 

SMi EVENT – BioBanking 2017!

SMi is delighted to announce its 7th Annual conference on BioBanking taking place in London, UK on the 14th and 15th of June 2017.

200X200

SMi’s 7th annual conference on Biobanking will bring together Europe’s leading biorepositories, regulatory representatives and scientific pioneers to strengthen knowledge in biosample management as well as explore future advances in areas such as mobile bio-banking and cloud based sample management. Understanding the ethical and regulatory framework as well as the impact of the General Data Protection Regulation (GDPR) on collaborative science in Europe will be a major focus. Plus, don’t miss keynote addresses from a selection of European biobanks currently adding value to clinical research through successful biobanking strategies including the European Sperm Bank, UK Biobank, UCL Baby Biobank, Auria Biobank and more.

Exclusive updates from the European Commission and NIBSC-MHRA, will be just some of the event highlights for 2017. Join us this June for innovative discussions through a series of interactive presentations, panel discussions and roundtables, and address relevant and critical issues on how to improve your biobanking practice.

For details visit the website at http://www.bio-banking-event.com/bentham or contact the team on Tel: +44 (0)20 7827 6000 / Email: events@smi-online.co.uk

Journal: Current Pharmaceutical Design

EBook: Frontiers in Drug Design & Discovery

SMi EVENT – 4th Peptides Event!

SMi Group’s 4th Peptides Conference will return to London this July to provide you two days of invaluable knowledge and networking opportunities.

2020

In the past few years, new technological advancements have influenced the growth of the global peptide therapeutics market with an increased number of peptides now in the pipeline of many biotech companies. Thus, the two-day conference is set to explore the latest peptide therapeutics advances to to improve the peptide production, reduce manufacturing costs, and allow for more accurate formulations to enhance overall drug delivery.

For details or to register, visit the website at http://www.peptidesevent.com/bentham

Journal: Current Protein & Peptide Science

EBook: Computational Biology of Embryonic Stem Cells

 

SMI EVENT – 7th Pharmaceutical Microbiology USA!

SMi is delighted to announce its 7th Pharmaceutical Microbiology USA conference taking place in San Diego, USA on the 8th and 9th of June 2017.

Pharma Micro USA 200x200 copy

Drawing on from the huge success of SMi’s Pharmaceutical Microbiology UK events, SMi is delighted to announce the launch of Pharmaceutical Microbiology USA. The seventh in its series, this event will take place in San Diego, on the 8th and 9th June 2017. Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology USA 2017 will address the current challenges and developing trends of the pharmaceutical microbiology field.

Through a series of presentations from handpicked industry experts, two pre-conference workshops and an additional interactive training session, the agenda will discuss hot topics such as rapid microbiology methods (RMM), risk assessment, challenges in endotoxin recovery, environmental monitoring, sterility assurance, data integrity and much more…

For details or to register, visit the website at www.pharma-microbiology-usa.com/bentham  or contact the team at +44(0) 207827 6000

Journal: Anti-Infective Agents

EBook: Frontiers in Anti-infective Drug Discovery